Gilead Sciences’ (GILD) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “sector perform” rating reissued by equities researchers at Royal Bank of Canada in a note issued to investors on Wednesday,Benzinga reports. They presently have a $84.00 target price on the biopharmaceutical company’s stock. Royal Bank of Canada’s target price points to a potential downside of […]
More Stories
Merchants Bancorp (NASDAQ:MBINN) Sees Significant Increase in Short Interest
Merchants Bancorp (NASDAQ:MBINN – Get Free Report) saw a significant increase in short interest in the month of December. As...
Short Interest in LeddarTech Holdings Inc. (NASDAQ:LDTC) Rises By 7,917.8%
LeddarTech Holdings Inc. (NASDAQ:LDTC – Get Free Report) was the recipient of a large increase in short interest in the...
Short Interest in Maris-Tech Ltd. (NASDAQ:MTEK) Rises By 302.2%
Maris-Tech Ltd. (NASDAQ:MTEK – Get Free Report) was the recipient of a significant increase in short interest in the month...
JPMorgan Chase & Co. Has $4.22 Billion Stock Position in iShares S&P 500 Growth ETF (NYSEARCA:IVW)
JPMorgan Chase & Co. cut its stake in iShares S&P 500 Growth ETF (NYSEARCA:IVW – Free Report) by 7.4% during...
JPMorgan Chase & Co. Lowers Stake in JPMorgan BetaBuilders Europe ETF (BATS:BBEU)
JPMorgan Chase & Co. trimmed its holdings in JPMorgan BetaBuilders Europe ETF (BATS:BBEU – Free Report) by 17.5% in the...
Sheriffs Nationwide Could Augment Trump’s Mass Deportation Plan
By Darlene McCormick Sanchez Sheriffs will likely play a key role in helping federal agents secure the border and deport...